Cann American Corp. current report, 29 May 2012

Business Context and Reporting Period

This Form 8-K was filed by Bioflamex Corporation (noted as Cann American Corp. in metadata) on May 29, 2012. The report discloses the entry into material definitive employment agreements with two key executives, effective retroactively to March 5, 2012.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The financial impact is limited to the compensation obligations outlined in the new executive agreements:

  • Base Salary: $240,000 per year for each executive (CEO and COO).
  • Equity Grant: 5,000,000 shares of common stock per executive, to be granted over 18 months.
  • Allowances: $2,000 per month automobile allowance per executive.
  • Severance: Up to 12 months of base salary and benefits upon termination without cause or voluntary resignation.

Material Changes

The primary material change is the formalization of executive compensation and tenure for Kristian Schiørring (CEO) and Henrik Dahlerup (COO). Both agreements extend their terms until March 5, 2015, with automatic three-year renewal options unless terminated with 90 days' notice.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of general risks. The primary contingency noted is the potential cash outflow for severance payments if either executive is terminated without cause or resigns voluntarily, triggering a 12-month payout obligation.

Investor Verification Checklist

  • Verify the total number of authorized shares to assess the dilution impact of the 10,000,000 shares granted to executives.
  • Confirm the company's current cash position to evaluate its ability to fund the $480,000 annual base salary increase and potential severance liabilities.
  • Review the full text of Exhibits 10.1 and 10.2 for specific definitions of "Cause" and performance metrics for discretionary bonuses.
  • Check for any pending litigation or regulatory issues related to the retroactive effective date of March 5, 2012.